Comparison of SNCG and NEFH Promoter–Driven Expression of Human SIRT1 Expression in a Mouse Model of Glaucoma
Translational Vision Science & Technology · 2024
DOI: 10.1167/tvst.13.8.37 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Translational Vision Science & Technology, 2024. Verfasst von Nuala O'Neill und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Sirtuin 1, Promoter Regions, Genetic, Disease Models, Animal, Retinal Ganglion Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Purpose
Adeno-associated virus (AAV) demonstrates promise in delivering therapeutic genes to retinal ganglion cells (RGCs). Delivery of neuroprotective genes is constrained by packaging size and/or cell selectivity. This study compares the ability of the RGC-selective gamma-synuclein (SNCG) promoter and the smaller RGC-selective neurofilament heavy chain (NEFH) promoter, as well as portions of the RGC-selective atonal bHLH transcription factor 7 (ATOH7) enhancer, to drive gene expression in RGCs.
Methods
AAV2 constructs with green fluorescent protein (GFP) or human sirtuin 1 (hSIRT1) driven by cytomegalovirus (CMV) enhancer and NEFH promoter (AAV2-eCMV-NEFH) or distal active sequences of the ATOH7 enhancer (DiATOH7) with the SNCG promoter (AAV2-DiATOH7-SNCG) were intravitreally injected into C57BL/6J mice. RGCs were immunolabeled with Brn3a antibodies and counted. AAV constructs with the utmost transduction efficiency were used to test the therapeutic efficacy of the hSIRT1 gene in 12-week-old C57BL/6J mice subjected to microbead (MB)-induced intraocular pressure (IOP) elevation. Visual function was measured using optokinetic responses (OKRs).
Results
The eGFP transduction efficiency of AAV2-eCMV-NEFH was similar to that of AAV2-eCMV-SNCG and AAV2-DiATOH7-SNCG. When combined with the SNCG promoter, a larger ATOH7 enhancer was less efficient than the shorter DiATOH7 enhancer. Similarly, the hSIRT1 efficiency of AAV2-eCMV-NEFH was similar to that of AAV2-eCMV-SNCG. The latter two vectors were equally efficient in increasing RGC survival and improving visual function in the mouse model of MB-induced IOP elevation.
Conclusions
SNCG and NEFH promoters represent two equally efficient and comparable RGC selective promoter sequences; however, the NEFH promoter offers a smaller packaging size. Translational Relevance: Smaller enhancer-promoter combinations can be used to deliver larger genes in human cells and for treatment in optic neuropathies including glaucoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Pennsylvania, Philadelphia, PA, USA.
- F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
- Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Förderung
- NEI NIH HHS
Zitieren
APA
O'Neill, N., Meng, M., Chaqour, B., Dine, K., Sarabu, N., Pham, J. C., Shindler, K. S., & Ross, A. G. (2024). Comparison of SNCG and NEFH Promoter–Driven Expression of Human SIRT1 Expression in a Mouse Model of Glaucoma. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.13.8.37
Vancouver
O'Neill N, Meng M, Chaqour B, Dine K, Sarabu N, Pham JC, et al. Comparison of SNCG and NEFH Promoter–Driven Expression of Human SIRT1 Expression in a Mouse Model of Glaucoma. Translational Vision Science & Technology. 2024. doi:10.1167/tvst.13.8.37
BibTeX
@article{ONeill2024,
author = {O'Neill, Nuala and Meng, Miranda and Chaqour, Brahim and Dine, Kimberly and Sarabu, Neha and Pham, Jennifer C and Shindler, Kenneth S and Ross, Ahmara G},
title = {Comparison of SNCG and NEFH Promoter–Driven Expression of Human SIRT1 Expression in a Mouse Model of Glaucoma},
journal = {Translational Vision Science & Technology},
year = {2024},
doi = {10.1167/tvst.13.8.37}
}
EUVIMED